Rb and p16 expression in non-small cell lung cancer (NSCLC).

被引：0
作者：
Flieder, DB
Brambilla, E
Rush, W
Przygodzki, R
Fleming, M
Freedman, A
Travis, W
Caporaso, N
Guinee, D
Bennett, W
Jones, R
Trastek, V
Pairolero, P
Tazelaar, H
Jett, J
Midthun, D
Liotta, L
Harris, CC
机构：
[1] NCI, Human Carcinogenesis Lab, Bethesda, MD 20892 USA
[2] NCI, Genet Epidemiol Branch, Bethesda, MD 20892 USA
[3] CHRU, Pathol Cellulaire Lab, Grenoble, France
[4] AFIP, Washington, DC USA
[5] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA
[6] Mayo Clin, Rochester, MN USA
来源：
MODERN PATHOLOGY | 1998年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：173A / 173A
页数：1
相关论文
共 50 条
  • [31] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
    Christian Manegold
    Petr Zatloukal
    Kurt Krejcy
    Johannes Blatter
    Investigational New Drugs, 2000, 18 : 29 - 42
  • [32] BRCAness in non-small cell lung cancer (NSCLC).
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha H. K.
    Michel, Loren S.
    Maggi, Leonard B.
    Watson, Mark
    Guebert, Kalin
    Carpenter, Danielle
    Sleckman, Barry P.
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Expression and localization of cyclooxygenase isoforms in non-small cell lung cancer (NSCLC)
    Watkins, DN
    Lenzo, JC
    Segal, A
    Garlepp, MJ
    Thompson, PJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A203 - A203
  • [34] p27 immunohistochemical expression in non-small cell lung carcinomas (NSCLC)
    Okby, N
    Jones, R
    Khan, M
    Travis, W
    Liotta, L
    Caporaso, N
    Tazelaar, H
    Pairolero, P
    Traslek, V
    Miothun, D
    Jett, J
    Harris, C
    LABORATORY INVESTIGATION, 1999, 79 (01) : 185A - 185A
  • [35] Cooperative role of telomerase activity and p16 expression in the prognosis of non-small-cell lung cancer
    González-Quevedo, R
    Iniesta, P
    Morán, A
    de Juan, C
    Sánchez-Pernaute, A
    Fernández, C
    Torres, A
    Díaz-Rubio, E
    Balibrea, JL
    Benito, M
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 254 - 262
  • [36] Biomarkers in Non-Small Cell Lung Cancer: Expression of PD-L1 Protein and p16 in Squamous Cell Carcinoma Histologic Subtype
    Sua, L.
    Lores, J.
    Aguirre, M.
    Castro, A.
    Fernandez-Trujillo, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S982 - S983
  • [37] Decreased expression of p16 and p27 in non-small cell long carcinoma (NSCLC) associated with unfavorable clinical outcome.
    Al-Mudhafer, S
    Al-Salameh, A
    Ryes, L
    Ramnath, N
    Anderson, T
    Tan, D
    LABORATORY INVESTIGATION, 2001, 81 (01) : 216A - 216A
  • [38] Expression of p42.3 in non-small cell lung cancer
    Zhang, Xinmu
    Nie, Xin
    Long, Junyu
    Yu, Jiangyong
    Zhang, Ping
    Liu, Yan
    Wu, Xiaonan
    Bai, Yi
    Mao, Jinzhu
    Liu, Xiaochuan
    Yuan, Yue
    Zhao, Haitao
    Li, Lin
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (13)
  • [39] ODC mRNA expression in curatively resected non-small cell lung cancer (NSCLC)
    Grimminger, Peter P.
    Danenberg, Peter V.
    Daniel, Vallboehmer
    Schneider, Paul M.
    Hoelscher, Arnulf H.
    Brabender, Jan
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : S239 - S239
  • [40] Predictive significance of thymidylate synthase expression in non-small cell lung cancer (NSCLC)
    Dobra, J.
    Kulda, V.
    Pesta, M.
    Babuska, V.
    Pesek, M.
    Racek, J.
    FEBS JOURNAL, 2013, 280 : 319 - 319
12345